Turquoise Health Raises $40M Series C for Pricing Platform
Turquoise Health, a Nashville-based end-to-end healthcare pricing platform, has raised $40M in Series C funding led by Oak HC/FT. The platform aggregates data from hospital and payer machine-readable files to deliver precision pricing, contract intelligence, and compliance tools for providers, payers, employers, and life sciences firms. The capital will expand AI-powered workflows, transaction capabilities, and team growth to over 200 employees.
CMS Mandates Drive Transparency Surge
The round arrives as CMS finalizes CY 2026 rules enhancing hospital price transparency, with enforcement starting April 2026 per CMS fact sheet. Ease Health emerged from stealth with $41M Series A led by Andreessen Horowitz just days prior. Turquoise Health's focus on parsing MRFs for negotiated rates positions it to capitalize on these regulatory tailwinds amid persistent compliance gaps.
$1T Admin Waste Fuels Urgency
U.S. healthcare faces $1T in annual administrative waste, exacerbated by opaque pricing and contracts. Hospitals and payers struggle with compliance to price transparency rules, with reports showing weak disclosure across 10 U.S. markets per Health Journalism. Current solutions often limit to list prices or consumer tools, leaving negotiated rates siloed and unusable for enterprise decisions.
MRF Data Powers Contract Intelligence
Turquoise Health ingests all U.S. hospital MRFs into a searchable database, enabling AI tools like AskTQ for traceable insights and contract modeling. Products span Analyze for pricing analytics, Contracts for negotiation intelligence, and Transactions for payment management. Unlike consumer-focused rivals like Healthcare Bluebook, it serves B2B needs with 65,000+ contracts mapped.
As CEO Chris Severn noted:
"No other company has built what we’ve built. The combination of our data moat… is unique to Turquoise."
AI Transactions Redefine Efficiency
The platform's Knowledge Graph links rates, contracts, and policies, detecting underpayments and denials proactively. Free public tools like Payer Transparency Scores for 97 payers and Medicare Pricer for 10,000 claims monthly build ecosystem influence. This end-to-end approach differentiates from analytics-only players like Trilliant Health.
Growth VCs Validate Pricing Bet
Oak HC/FT led the round, with participation from Andreessen Horowitz, Adams Street Partners, and Yosemite. Repeat investors signal conviction in Turquoise's evolution from data aggregator to transaction OS. Oak HC/FT's healthcare payments portfolio, including Rialtic, aligns with reducing friction in pricing and revenue cycle.
RCM Market Scales to $517B
Revenue cycle management hits $169B in 2026, growing to $517B by 2033 at 10.15% CAGR per Mordor Intelligence. Price transparency systems reach $2.35B in 2026, expanding to $4.41B by 2030 at 17.1% CAGR per ResearchAndMarkets. Turquoise serves 300+ customers, including 10 of 25 top health systems and 5 of 5 national payers.
Domain Experts Lead Charge
Co-founder CEO Chris Severn brings 10+ years modeling hospital managed care contracts and testified before Congress on transparency. CTO Adam Geitgey holds patents in scalable software and ML systems from Groupon. This duo's expertise powers the platform's precision in a complex revenue cycle landscape.
Transactions OS Accelerates Post-Funding
Funds target scaling the Contracts platform to eliminate administrative friction and guarantee all-inclusive prices. Plans include AI expansion, transaction OS buildout, and team growth beyond 170 members. With 35% of users across multiple products, Turquoise eyes broader adoption amid CMS enforcement.